Loading patent…
Assignee3M Innovative Properties Company
InventorsJohn C. Hedenstrom, Michael J. Jozwiakowski, Mark Martinez, Kenneth R. Phares, Kenneth Trofatter, Jr.
Estimating the term…
A system for treating a condition associated with a mucosal surface, the system comprising an immune response modifier (IRM) compound chosen from imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, 1,2-bridged imidazoquinoline amines, and pharmaceutically acceptable salts thereof and an applicator device for applying the IRM compound to the mucosal surface. This system of IRM compounds and applicator may be used to treat conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia.
A system for treating a condition associated with a mucosal surface, the system comprising a pharmaceutical formulation and an applicator device for applying the formulation to the mucosal surface, wherein the pharmaceutical formulation comprises:
A system for treating a condition associated with a mucosal surface, the system comprising:
A system for treating a condition associated with a mucosal surface, the system comprising:
A system for treating a condition associated with a mucosal surface, the system comprising:
A system for treating a condition associated with a mucosal surface, the system comprising a pharmaceutical formulation and an applicator device for applying the formulation to the mucosal surface, wherein the pharmaceutical formulation comprises:
A system for treating a condition associated with a mucosal surface, the system comprising:
A system for treating a condition associated with a mucosal surface, the system comprising:
A system for treating a condition associated with a mucosal surface, the system comprising:
Dependencies are inferred from the claim text.